422 related articles for article (PubMed ID: 10915163)
21. Intramuscular hepatitis B immune globulin combined with lamivudine in prevention of hepatitis B recurrence after liver transplantation.
Yan ML; Yan LN; Li B; Zeng Y; Wen TF; Wang WT; Yang JY; Xu MQ; Li ZH; Chen YB
Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):360-3. PubMed ID: 16911931
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B prophylaxis in living donor liver transplantation: single center experience.
Yaprak O; Dayangac M; Balci D; Bas K; Yuzer Y; Tokat Y
Hepatogastroenterology; 2010; 57(102-103):1178-82. PubMed ID: 21410054
[TBL] [Abstract][Full Text] [Related]
23. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
Liu J; Wu GC; Zhang ZT; Wu P; Zhang D; Sun MC; Gao DC; Wang Y; Jia JD; Wang BE
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):976-9. PubMed ID: 16194352
[TBL] [Abstract][Full Text] [Related]
24. Minimization of anti-hepatitis B surface antigen immunoglobulins for prophylaxis of hepatitis B viral recurrence in the first month after liver transplantation: the meaning of HBsAg quantitative level at the time of transplant.
Tandoi F; Nada E; Pittaluga F; Fop F; Lupo F; Romagnoli R; Salizzoni M
Transplant Proc; 2014 Sep; 46(7):2308-11. PubMed ID: 25242775
[TBL] [Abstract][Full Text] [Related]
25. [Liver transplantation for chronic hepatitis B patients with lamivudine monotherapy or lamivudine combined with individualized low-dose hepatitis B immunoglobulin treatment].
Jiao ZY; Yan LN; Li B; Zeng Y; Wen TF; Lu SC; Zhao JC; Wang WT; Xu MQ; Yang JY; Li ZH; Ma YK; Zhang ZW; Chen ZY
Zhonghua Gan Zang Bing Za Zhi; 2007 Nov; 15(11):804-8. PubMed ID: 18073060
[TBL] [Abstract][Full Text] [Related]
26. Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation.
Suehiro T; Shimada M; Kishikawa K; Shimura T; Soejima Y; Yoshizumi T; Hashimoto K; Mochida Y; Maehara Y; Kuwano H
Liver Int; 2005 Dec; 25(6):1169-74. PubMed ID: 16343068
[TBL] [Abstract][Full Text] [Related]
27. Use of combined treatment of hepatitis B immune globulin and lamivudine as prevention of hepatitis B virus recurrence in liver allograft.
Albeniz Arbizu E; Barcena Marugan R; Oton Nieto E; Mateo Lindeman M; Garcia Gonzalez M; de Vicente Lopez E; Moraleda Garcia G
Transplant Proc; 2003 Aug; 35(5):1844-5. PubMed ID: 12962818
[TBL] [Abstract][Full Text] [Related]
28. Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease.
Dickson RC; Terrault NA; Ishitani M; Reddy KR; Sheiner P; Luketic V; Soldevila-Pico C; Fried M; Jensen D; Brown RS; Horwith G; Brundage R; Lok A
Liver Transpl; 2006 Jan; 12(1):124-33. PubMed ID: 16382463
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation.
Cholongitas E; Vasiliadis T; Antoniadis N; Goulis I; Papanikolaou V; Akriviadis E
Transpl Infect Dis; 2012 Oct; 14(5):479-87. PubMed ID: 22624695
[TBL] [Abstract][Full Text] [Related]
30. Prophylaxis against recurrence of HBV hepatitis after living-donor liver transplantation.
Tashiro H; Itamoto T; Fudaba Y; Ohdan H; Fukuda S; Kohashi T; Amano H; Ishiyama K; Ide K; Ogawa T; Shishida M; Irei T; Ushitora Y; Ohira M; Takahashi S; Chayama K; Asahara T
Hepatogastroenterology; 2008; 55(86-87):1746-9. PubMed ID: 19102383
[TBL] [Abstract][Full Text] [Related]
31. Evolving experience of hepatitis B virus prophylaxis in liver transplantation.
Honaker MR; Shokouh-Amiri MH; Vera SR; Alloway RR; Grewal HP; Hardinger KL; Kizilisik AT; Bagous T; Trofe J; Stratta RJ; Egidi MF; Gaber AO
Transpl Infect Dis; 2002 Sep; 4(3):137-43. PubMed ID: 12421458
[TBL] [Abstract][Full Text] [Related]
32. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
[TBL] [Abstract][Full Text] [Related]
33. Evolving strategies to prevent HBV recurrence.
Roche B; Samuel D
Liver Transpl; 2004 Oct; 10(10 Suppl 2):S74-85. PubMed ID: 15382222
[TBL] [Abstract][Full Text] [Related]
34. Living related liver transplantation for hepatitis B-related liver disease without hepatitis B immune globulin prophylaxis.
Wadhawan M; Gupta S; Goyal N; Taneja S; Kumar A
Liver Transpl; 2013 Sep; 19(9):1030-5. PubMed ID: 23788470
[TBL] [Abstract][Full Text] [Related]
35. Prophylaxis against hepatitis B virus recurrence after liver transplantation: a registry study.
Shen S; Jiang L; Xiao GQ; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Xu MQ; Wei YG
World J Gastroenterol; 2015 Jan; 21(2):584-92. PubMed ID: 25593480
[TBL] [Abstract][Full Text] [Related]
36. Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation.
Han SH; Martin P; Edelstein M; Hu R; Kunder G; Holt C; Saab S; Durazo F; Goldstein L; Farmer D; Ghobrial RM; Busuttil RW
Liver Transpl; 2003 Feb; 9(2):182-7. PubMed ID: 12548512
[TBL] [Abstract][Full Text] [Related]
37. Antiviral Combination Therapy With Low-Dose Hepatitis B Immunoglobulin for the Prevention of Hepatitis B Virus Recurrence in Liver Transplant Recipients: A Single-Center Experience.
Akcam AT; Ulku A; Rencuzogullari A; Eray IC; Okoh A; Kuran S; Dalcı K; Yalav O; Parsak CK; Sakman G; Demiryurek H
Transplant Proc; 2015 Jun; 47(5):1445-9. PubMed ID: 26093739
[TBL] [Abstract][Full Text] [Related]
38. Low-dose short-term hepatitis B immunoglobulin with high genetic barrier antivirals: the ideal post-transplant hepatitis B virus prophylaxis?
Choudhary NS; Saraf N; Saigal S; Mohanka R; Rastogi A; Goja S; Menon PB; Soin AS
Transpl Infect Dis; 2015 Jun; 17(3):329-33. PubMed ID: 25682715
[TBL] [Abstract][Full Text] [Related]
39. Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
Naoumov NV; Lopes AR; Burra P; Caccamo L; Iemmolo RM; de Man RA; Bassendine M; O'Grady JG; Portmann BC; Anschuetz G; Barrett CA; Williams R; Atkins M
J Hepatol; 2001 Jun; 34(6):888-94. PubMed ID: 11451173
[TBL] [Abstract][Full Text] [Related]
40. Combination therapy in liver transplant recipients with hepatitis B virus without hepatitis B immune globulin.
Neff GW; Kemmer N; Kaiser TE; Zacharias VC; Alonzo M; Thomas M; Buell J
Dig Dis Sci; 2007 Oct; 52(10):2497-500. PubMed ID: 17404847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
